Zobrazeno 1 - 10
of 12 743
pro vyhledávání: '"Feustel, A."'
Publikováno v:
Journal of Pediatric Urology; Oct2024, Vol. 20 Issue 5, p1012-1013, 2p
Autor:
Aicher, Annalena, Hillmann, Stefan, Feustel, Isabel, Michael, Thilo, Möller, Sebastian, Minker, Wolfgang
In the last decade, crowdsourcing has become a popular method for conducting quantitative empirical studies in human-machine interaction. The remote work on a given task in crowdworking settings suits the character of typical speech/language-based in
Externí odkaz:
http://arxiv.org/abs/2411.11137
Autor:
Großmann, Katrin
Publikováno v:
Soziopolis: Gesellschaft beobachten
Peter Bescherer, Anne Burkhardt, Robert Feustel, Gisela Mackenroth und Luzia Sievi (Hg.): Urbane Konflikte und die Krise der Demokratie: Stadtentwicklung, Rechtsruck und Soziale Bewegungen. Münster: Westfälisches Dampfboot 2021. 978-3-89691-057-8
Externí odkaz:
https://www.ssoar.info/ssoar/handle/document/79023
Autor:
Hanks, Patrick, Lenarčič, Simon
Publikováno v:
Dictionary of American Family Names, 2 ed., 2022.
Externí odkaz:
http://www.oxfordreference.com/view/10.1093/acref/9780190245115.001.0001/acref-9780190245115-e-23965
Autor:
Stoppe, Sebastian
Publikováno v:
Zeitschrift für Politik, 2016 Jun 01. 63(2), 229-231.
Externí odkaz:
http://www.jstor.org/stable/43855116
Publikováno v:
Continence, Vol 12, Iss , Pp 101696- (2024)
Purpose:: Ongoing monitoring of adverse events after medication approval can provide a real-world gauge of medication side effects in a larger, more diverse sample size. We report differences in post-marketing adverse event rates among commonly presc
Externí odkaz:
https://doaj.org/article/307b26baf1794306912e4b489685fa41
Supplementary figures S1-6, tables S1-6, and e-References for Feustel et al. "Risks and benefits of unapproved, disease-modifying treatments for neurodegenerative disease".
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ecfae556d7478ad37e5064999e76e23
Autor:
Jens Hälterlein
Publikováno v:
Behemoth : a Journal on Civilisation, Vol 04, Iss 01, Pp 124-131 (2011)
Externí odkaz:
https://doaj.org/article/97a587048ffe45cabed47f1a83afbca9
Publikováno v:
Environmental Health, Vol 23, Iss 1, Pp 1-14 (2024)
Abstract Risk assessment (RA) of microbial secondary metabolites (SM) is part of the EU approval process for microbial active substances (AS) used in plant protection products (PPP). As the number of potentially produced microbial SM may be high for
Externí odkaz:
https://doaj.org/article/055ab8dc6abe42a6bb7a52fd076569bc